Call For Proposals:ANGELINI FOR FUTURE 2021 – Support for independent Research in Rare Diseases
Call For Proposals: ANGELINI FOR FUTURE 2021 – Support for independent Research in Rare Diseases
On January 29th, 2021 Angelini and INCIPIT, sharing the scope to promote high quality research on drugs, launch the first edition of call for proposals – Angelini for Future 2021- with the purpose to provide funding for the best studies to investigate drug repurposing in rare diseases or in conditions with high-unmet medical needs in CNS, targeting the paediatric population.
15 October Meeting INCIPIT-AOPI (Associazione Ospedali Pediatrici Italiani)
On 15th October 2018, INCIPIT meets Associazione Ospedali Pediatrici Italiani -AOPI-in Trieste. The Chairman of INCIPIT Professor Paolo Rossi and Dr. Paolo Petralia (Chairman of AOPI) have finalized a Cooperation Agreement. The parties mutually acknowledge the common desire to collaborate and to facilitate an increasingly effective interaction between the Italian paediatric realities, to achieve common goals and to favor the development of the future paediatric clinical trials in Italy.
New conect4children Consortium Selects Inaugural Research Portfolio to Advance Development of Innovative Paediatric Medicines
Novel Cross-sector Collaboration Establishes Pan European Paediatric Clinical Trial Network to Improve Infrastructure and Facilitate Development of Medicines for Children in Europe PADOVA – 29 April 2019 – The conect4children (c4c) consortium today announced the selection of its first portfolio of pan-European paediatric studies aimed at advancing the understanding of high priority … Continue reading “New conect4children Consortium Selects Inaugural Research Portfolio to Advance Development of Innovative Paediatric Medicines”
INCIPIT Open Vacancies
INCIPIT currently has very exciting opportunity to hire in Rome a Research Fellow and an Accounting/Amministrative Assistant for the coordinating centre of the Consortium led by Paediatric Hospital Bambino Gesù of Rome.
Please feel free to send your own job application at any time.
2018 Annual workshop of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA): 7–8 JUNE 2018.
The European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) is a network of research networks, investigators and centres with recognised expertise in performing clinical studies in children.
Enpr-EMA’s main objective is to facilitate studies in order to increase availability of medicinal products authorised for use in the paediatric population.
Enpr-EMA will hold its tenth annual workshop on 7-8 June 2018 at EMA and “An holistic approach to paediatric research” will be the overall theme.
This workshop will bring together relevant stakeholders to discuss requirements, barriers and opportunities for conducting high-quality clinical studies in children.
Multi-stakeholder workshop to further improve the implementation of the Paediatric Regulation
The workshop, organised by the European Medicines Agency (EMA) and the European Commission, follows the publication of the Commission’s ten-year report on implementation of the Paediatric Regulation and the state of paediatric medicines in the European Union.
The aim is to discuss potential improvements of the implementation of the Regulation. It will explore opportunities regarding paediatric needs, timely completion of paediatric investigation plans (PIP), and processes and expectations for handling PIP applications. This workshop is a crucial step for the development of a concrete action plan to address challenges identified with medicine development for children in Europe. Invited stakeholders include patients, academia, healthcare professionals and industry.
INCiPiT and the Independent Research on drugs funded by Italian Medicine Agency –AIFA Call 2017
The Italian Medicine Agency (AIFA) has launched the seventh call for proposals on independent research (Bando AIFA 2017)
It represents one of the strategic tasks assigned to AIFA by legislation which goes to reward projects able to enrich clinical and therapeutic knowledge in areas of lesser interest for profit research.
The call for proposals is aimed at investigators, public and private entities operating in the field of health care and scientific research not for profit.
In this call, five main areas (three in Bando AIFA 2016) of drug research has been included in the program.
The deadline for submitting the project will be the 31th of January 2018.
EPTRI – European Paediatric Translational Research Infrastructure.
A great success for paediatric medicines development.
The ID-EPTRI (European Paediatric Translational Research Infrastructure) project, coordinated by CVBF and submitted within the INFRADEV-2016-2017 single-stage call for proposals, aimed to create the framework for a new paediatric Research Infrastructure (RI) has been successfully evaluated and granted 3.00 million Euro in funding from the European Commission.
The project will develop a new RI, EPTRI, that is complementary to the existing Biomed Research Infrastructures acting as a ‘Paediatric Common Service’ in the ESFRI Scenario. The project involves 26 partners from EU and non-EU countries including consolidated RIs, top-level universities, scientific and clinical centres of excellence in Europe and is aimed to create a Conceptual Design Report (CDR) to realize the European paediatric RI.
INCiPiT will actively participate into the project.
IMI2 launched the call
The Innovative Medicines Initiative (IMI), the joint undertaking between the European Union and the pharmaceutical industry association EFPIA, has launched IMI2 – Call 10, with a specific topic dedicated to the paediatric clinical trials.
Specifically, the call is focused on the creation of a large collaborative paediatric network that will facilitate the development and availability of new drugs and other therapies, and the expansion of knowledge about drugs currently used in the paediatric population.
INCiPiT will participate to this call as the Italian National Hub for the paediatric research.
Promoting high-quality clinical research in children through strengthened international collaboration.
In London on 16th May 2017 the ninth annual workshop of the European network of paediatric research at the EMA (Enpr-EMA) will take place.
Medicines for children: the point on research and innovative cares
TEDDY, the first paediatric Network of Excellence in Europe, has made the point on research and innovative cares for children. The Italian contribution and the new INCiPiT research network coordinated by the Paediatric Children Hospital Bambino Gesù was presented during a meeting held on December 19th 2016 at the Hospital.
Towards better medicines for children: PedCRIN project builds research infrastructure
On 31st of January, the European Clinical Research Infrastructure Network (ECRIN) has announced the launch of the Paediatric Clinical Research Infrastructure Network (PedCRIN).
The three-year project brings together ECRIN and the founding partners of the European Paediatric Clinical Trial Research Infrastructure (EPCT-RI) to develop capacity for the management of multinational paediatric clinical trials.
Launch of PedCRIN call for multinational clinical studies in children and neonates
The Paediatric Clinical Research Infrastructure Network (PedCRIN) has launched the call for multinational clinical studies in children and neonates. PedCRIN is a four-year project funded by the European Union’s Horizon 2020 programme, aimed to bring together the European Clinical Research Infrastructure Network (ECRIN) and the founding partners of the European Paediatric Clinical Trial Research Infrastructure … Continue reading “Launch of PedCRIN call for multinational clinical studies in children and neonates”